| Ytd | 76.60% | |
| 1y | 58.40% |
| Open | 4.21 | Prev Close | 4.23 | Low | 4.14 | High | 4.25 | Mkt Cap | 2.20B |
| Vol | 3.60M | Avg Vol | 6.12M | EPS | -0.05 | P/E | N/A | Forward P/E | 27.67 |
| Beta | 2.48 | Short Ratio | 5.70 | Inst. Own | 33.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-04 | 50-d Avg | 4.60 | 200-d Avg | 3.09 | 1yr Est | 5.17 |
CLOV News
WILMINGTON, Del., Aug. 31, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV)
Clover Health Investments, Corp. leverages its AI-powered Clover Assistant to drive lower claims cos
Clover Health Investments (CLOV) is rated Hold, with operational execution but a cautious outlook du
Clover Health (CLOV) has delivered strong growth, profitability, and improved guidance, supporting m
Clover Health Investments NASDAQ: CLOV is positioning its Medicare Advantage model around earlier id
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and ra
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporti
Clover Health Investments, Corp. (CLOV) Q2 2026 Earnings Call Transcript
Clover Health Investments NASDAQ: CLOV reported second-quarter results that showed continued Medicar
Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&
Clover Health Investments (NASDAQ:CLOV) raises FY2026 sales outlook from $2.810 billion-$2.920 billi
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat th
Business Highlights: Delivered strong second quarter 2026 GAAP Net Income alongside continued market
Clover Health (NASDAQ:CLOV) has spent years as a speculative bet on a technology-led Medicare Advant
The disposition involved 62,711 shares at a weighted average price of $4.67 per share, totaling ~$29
WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV)
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a
Clover Health Investments said in a regulatory filing on Friday that it detected unusual login activ
WILMINGTON, Del., July 09, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV)
SAN FRANCISCO, July 07, 2026 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly
CEO Andrew Toy sold 313,476 shares of Common Stock for a transaction value of ~$1.67 million as of J
Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 milli
Director Carladenise Edwards sold 67,160 shares for a transaction value of approximately ~$230,000 o
Jim Cramer endorsed Vistra, expressed caution on Fair Isaac over AI risks: "I'm not going to
https://www.sec.gov/ix?doc=/Archives/edgar/data/1801170/000180117026000153/clov-20260615.htm
UBS analyst Jonathan Yong maintains Clover Health Investments (NASDAQ:CLOV) with a Neutral and ra
Clover Health Investments Corp. (NASDAQ:CLOV) shares are extending yesterday's 18.9% surge Thursday,
Clover Health shares are extending Wednesday's 18.9% surge after a court-ordered Medicare upgrad
US stocks down, Dow Jones fell 150 pts on Wed. Caseys General Stores Inc (CASY) shares up 14.4% afte
On June 9, 2026, CMS informed Clover that, consistent with the Court's order, it has recalculate
This healthcare technology company focused on Medicare Advantage plans saw a notable insider sale fo
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a
Cramer criticizes Clover Health's quarterly results, recommends Amkor for semiconductor packagin
US stock futures higher, Lowe's shares fall after reporting earnings. Other stocks declining in
Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript
CLOV posts 62% revenue growth in Q1 as Medicare Advantage membership surges and AI-driven care initi
Clover Health Investments, Corp. (CLOV) came out with quarterly earnings of $0.07 per share, in line
Clover Health Investments (NASDAQ:CLOV) affirms FY2026 sales outlook from $2.810 billion-$2.920 bill
Clover Health Investments (NASDAQ:CLOV) reported quarterly earnings of $0.05 per share which beat th
Clover Health Investments, Corp. (Nasdaq: CLOV) ("Clover" or the "Company"), a physi
Canaccord Genuity analyst Richard Close maintains Clover Health Investments (NASDAQ:CLOV) with a
Counterpart Health, Inc. ("Counterpart"), a wholly owned subsidiary of Clover Health Investm
Full Year 2026 Guidance:Average Medicare Advantage membership of 154,000 - 158,000, representing 46%
Clover Health Investments (NASDAQ:CLOV) reported quarterly losses of $(0.10) per share which met the
Clover Health Investments is trading lower Tuesday afternoon after the Trump administration proposed
https://www.wsj.com/health/healthcare/trump-administration-proposes-keeping-steady-the-rates-medicar